🔎 Trials Near Me

Akèy › Kansè lestomak › Minnesota › Rochester

Etid klinik pou Kansè lestomak nan Rochester, MN

9 etid pou Kansè lestomak ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Research Site, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06005493

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Ap rekriteFaz 1
  • Mayo Clinic - Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07213791

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

Ap rekriteFaz 3
  • Mayo Clinic Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07217704

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

Ap rekriteFaz 1
  • Mayo Clinic Cancer Center, Rochester
  • Mayo Clinic, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT06131840

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Ap rekriteFaz 1/2
  • Mayo Clinic in Rochester, Minnesota, Rochester
Laj 18 a 90 · Tout sèks · Mizajou Jul 6, 2026 · NCT06710756

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Ap rekriteFaz 1/2
  • Mayo Clinic, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Mar 27, 2026 · NCT06395519

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Mayo Clinic, Rochester
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

Etid Kansè lestomak nan lòt vil

Lòt etid nan Rochester

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.